Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy of Norfloxacin Prophylaxis to Prevent Spontaneous Bacterial Peritonitis: A Systematic Review and Meta-Analysis
Marcus M. Mücke, Victoria T. Mücke, Christiana Graf, et al.
Clinical and Translational Gastroenterology (2020) Vol. 11, Iss. 8, pp. e00223-e00223
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Liver cirrhosis
Pere Ginés, Aleksander Krag, Juan G. Abraldeṣ, et al.
The Lancet (2021) Vol. 398, Iss. 10308, pp. 1359-1376
Closed Access | Times Cited: 955
Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
Scott W. Biggins, P. Angeli, Guadalupe García‐Tsao, et al.
Hepatology (2021) Vol. 74, Iss. 2, pp. 1014-1048
Closed Access | Times Cited: 514
Gut–liver axis: barriers and functional circuits
Oliver Pabst, Mathias W. Hornef, Frank G. Schaap, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 7, pp. 447-461
Closed Access | Times Cited: 162
Infections in cirrhosis
Salvatore Piano, Chalermrat Bunchorntavakul, Sebastián Marciano, et al.
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 8, pp. 745-757
Closed Access | Times Cited: 18
The search for disease-modifying agents in decompensated cirrhosis: From drug repurposing to drug discovery
Paolo Caraceni, Juan G. Abraldeṣ, Pere Ginès, et al.
Journal of Hepatology (2021) Vol. 75, pp. S118-S134
Open Access | Times Cited: 45
Early Diagnosis and Prevention of Infections in Cirrhosis
Anand V. Kulkarni, Madhumita Premkumar, Juan Pablo Arab, et al.
Seminars in Liver Disease (2022) Vol. 42, Iss. 03, pp. 293-312
Open Access | Times Cited: 29
Terlipressin therapy is associated with increased risk of colonisation with multidrug‐resistant bacteria in patients with decompensated cirrhosis
Marcus M. Mücke, María Hernández‐Tejero, Wen Gu, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 7, pp. 877-888
Open Access | Times Cited: 6
Position paper on perioperative management and surgical risk in the patient with cirrhosis
J.A. Velarde-Ruiz Velasco, Javier Crespo, Aldo J. Montaño‐Loza, et al.
Revista de Gastroenterología de México (English Edition) (2024) Vol. 89, Iss. 3, pp. 418-441
Open Access | Times Cited: 5
Primary prophylaxis for spontaneous bacterial peritonitis is linked to antibiotic resistance in the Veterans Health Administration
Bryan D. Badal, Scott Silvey, Lyuba Dragilev, et al.
Hepatology (2023) Vol. 77, Iss. 6, pp. 2030-2040
Closed Access | Times Cited: 12
Antibiotics in decompensated liver disease - who, when and for how long?
Frederic Haedge, Tony Bruns
Expert Review of Gastroenterology & Hepatology (2025)
Closed Access
Role of Rifaximin in the Prognosis of Critically Ill Patients with Liver Cirrhosis
Zhaohui Bai, Congcong Li, Yongjie Lai, et al.
Antibiotics (2025) Vol. 14, Iss. 3, pp. 287-287
Open Access
Fluoroquinolones for the Prophylaxis of Spontaneous Bacterial Peritonitis in Patients with Liver Cirrhosis: Are They Losing Ground?
Simona Juncu, Horia Minea, A Lungu, et al.
Life (2025) Vol. 15, Iss. 4, pp. 586-586
Open Access
Impact of Quinolone Prophylaxis on Spontaneous Bacterial Peritonitis and Mortality in Cirrhosis Patients: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
Ajay Malvi, Nipun Verma, Mahalaqua Nazli Khatib, et al.
JGH Open (2025) Vol. 9, Iss. 4
Open Access
Multidrug-resistant bacterial infections in the liver transplant setting
Alberto Ferrarese, Marco Senzolo, Lolita Sasset, et al.
Updates in Surgery (2024)
Open Access | Times Cited: 3
A Machine Learning Algorithm Avoids Unnecessary Paracentesis for Exclusion of SBP in Cirrhosis in Resource-limited Settings
Scott Silvey, Nilang Patel, Jinze Liu, et al.
Clinical Gastroenterology and Hepatology (2024)
Closed Access | Times Cited: 2
Bacterial Infections in Acute-on-chronic Liver Failure: Epidemiology, Diagnosis, Pathogenesis, and Management
Zhaoyu Xu, Xiuding Zhang, Jian‐Zhang Chen, et al.
Journal of Clinical and Translational Hepatology (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 2
Synthesis of New Norfloxacin–Tin Complexes to Mitigate the Effect of Ultraviolet-Visible Irradiation in Polyvinyl Chloride Films
Marwa H. Fadhil, Emad͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏ Yousif, Dina S. Ahmed, et al.
Polymers (2022) Vol. 14, Iss. 14, pp. 2812-2812
Open Access | Times Cited: 11
Antimicrobial prophylaxis in decompensated cirrhosis: friend or foe?
Dominic Crocombe, Alastair O’Brien
Hepatology Communications (2023) Vol. 7, Iss. 9
Open Access | Times Cited: 5
Evidence-Based Commentary: Antibiotics for Prophylaxis of Spontaneous Bacterial Peritonitis
Ifrah Fatima, Anand V. Kulkarni
JOURNAL OF GASTROINTESTINAL INFECTIONS (2022) Vol. 12, Iss. 01, pp. 051-056
Open Access | Times Cited: 6
Indications for medical antibiotic prophylaxis and potential targets for antimicrobial stewardship intervention: a narrative review
Πέτρος Ιωάννου, Stamatis Karakonstantis, Jeroen Schouten, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 3, pp. 362-370
Open Access | Times Cited: 8
Norfloxacin versus alternative antibiotics for prophylaxis of spontaneous bacteria peritonitis in cirrhosis: a systematic review and meta-analysis
Shuailing Song, Yi Yang, Chong Geng, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Antibiotics in Chronic Liver Disease and Their Effects on Gut Microbiota
Nahúm Méndez‐Sánchez, Carlos E. Coronel-Castillo, Jacqueline Córdova‐Gallardo, et al.
Antibiotics (2023) Vol. 12, Iss. 10, pp. 1475-1475
Open Access | Times Cited: 3
Obeticholic Acid Decreases Intestinal Content of Enterococcus in Rats With Cirrhosis and Ascites
Kathleen Yan, Adelina Hung, Caitlin M. Parmer, et al.
Hepatology Communications (2021) Vol. 5, Iss. 9, pp. 1507-1517
Open Access | Times Cited: 6
Impact of colonization with multidrug-resistant organisms on antibiotic prophylaxis in patients with cirrhosis and variceal bleeding
Victoria T. Mücke, Kai‐Henrik Peiffer, Johanna Kessel, et al.
PLoS ONE (2022) Vol. 17, Iss. 5, pp. e0268638-e0268638
Open Access | Times Cited: 4
Antibiotic prophylaxis in patients with cirrhosis: Current evidence for clinical practice
Alberto Ferrarese, Nicola Passigato, Caterina Cusumano, et al.
World Journal of Hepatology (2021) Vol. 13, Iss. 8, pp. 840-852
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top